Result of Retail Offer

Manchester, UK - 29 September 2025: genedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, is pleased to announce that it has conditionally raised gross proceeds of approximately £0.33 million through the Retail Offer. The terms and conditions of the Retail Offer were announced by the Company at 5.03 p.m. on 23 September 2025.

Total demand received through the Retail Offer was approximately £0.68 million which exceeded the total amount available to be allocated under the Retail Offer which was capped at approximately £0.33 million. This cap includes the 10 per cent. scale up mechanism which given the level of retail shareholder demand has been exercised. Accordingly, a total of 164,875,000 Retail Offer Shares are therefore expected to be issued pursuant to the Retail Offer including 38,750,000 Retail Offer Shares subscribed for by three Directors of the Company as detailed in the Completion of Placing announcement which was issued by the Company on 24 September 2025.

Additional demand of £100,000 which was flagged in the Completion of Placing announcement has now been accepted into the Conditional Placing following the entering into of binding commitment with the investor. Accordingly, the Conditional Placing and the Retail Offer have together conditionally raised a total of approximately £2.82 million through the issue of 1,248,750,000 Conditional Placing Shares and 164,875,000 Retail Offer Shares. The Firm Placing completed on 26 September 2025 and raised gross proceeds of £800,000 for the Company through the issue of 400,000,000 Firm Placing Shares.

As a result, the Company has conditionally raised a total of approximately £3.62 million via the Placing and the Retail Offer which exceeds the required minimum amount needed to be raised in order for the Fundraising (other than the Firm Placing which has already completed) to become unconditional.

The Conditional Placing and the Retail Offer are still conditional on, inter alia, the passing of resolutions 1 and 2 at the General Meeting (expected to be convened for 15 October 2025 and Second Admission occurring no later than 8.00 a.m. on 16 October 2025 (or such later time and/or date as may be agreed between the Company, Peel Hunt and Allenby Capital being no later than 8.00 a.m. on 30 October 2025).

Application has been made to the London Stock Exchange for the admission of 1,413,625,000 New Ordinary Shares to trading on AIM ("Second Admission"). This comprises: (i) 1,248,750,000 Conditional Placing Shares; and (ii) 164,875,000 Retail Offer Shares. These New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Subject to, inter alia, the passing of the Resolutions, a further announcement will be made in due course in relation to the total number of voting rights of the Company from Second Admission.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the applicable announcement of the Fundraising made by the Company on 23 September 2025.

Product Governance Requirements

Solely for the purposes of the product governance requirements of Chapter 3 of the FCA Handbook Product Intervention and Product Governance Sourcebook (the "UK Product Governance Requirements") and/or any equivalent requirements elsewhere to the extent determined to be applicable, and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the UK Product Governance Requirements and/or any equivalent requirements elsewhere to the extent determined to be applicable, may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that the Placing Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each defined in Chapter 3 of the FCA Handbook Conduct of Business Sourcebook; and (ii) eligible for distribution through all permitted distribution channels (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, Peel Hunt and Allenby Capital will only procure investors who meet the criteria of professional clients and eligible counterparties.